Whats so powerful about this idea is that GLP-1 agonist medications would theoretically target the addictive behavior itself, rather than symptoms of the addiction
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 183,71 per year only 15,31 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout References Zelniker, T
doi:10.1111/bjd.18333
The AI tool was not used to generate original scientific content, analyze data, interpret results, or draw conclusions
Galactose ligand at high concentration decreased the internalization of nanoparticles in GLUT-1 expressing lung epithelial and human nasopharyngeal epidermal carcinoma cell lines [63]
Dr Hannan, the optician's clinical services director, said: "Weight loss injections are becoming increasingly common and can deliver important health benefits for many people